Evidence map›Paper›PMID 36625011›Full record

ArticleJournal of biomedical research2022

Peripheral CD4

Kai Chang, Wanlin Na, Chenxia Liu, Hongxuan Xu, Yuan Liu, Yanyan Wang, Zhongyong Jiang

Open access · diamondAbstract read
In one paragraph

Article in Journal of biomedical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Legend or Truth: Mature CD4Biomedicines · 2023
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Kai ChangDepartment of Medical Laboratory, The General Hospital of Western Theater Command, Chengdu, Sichuan 610083, China.
Wanlin NaDepartment of Medical Laboratory, The General Hospital of Western Theater Command, Chengdu, Sichuan 610083, China.
Chenxia LiuInstitute of Microbiology, Sichuan Center for Disease Control and Prevention, Chengdu, Sichuan 610044, China.
Hongxuan XuBiology Teaching and Research Group, Chengdu Experimental Foreign Languages School, Chengdu, Sichuan 611134, China.
Yuan LiuDepartment of Medical Laboratory, The General Hospital of Western Theater Command, Chengdu, Sichuan 610083, China.
Yanyan WangDepartment of Medical Laboratory, The General Hospital of Western Theater Command, Chengdu, Sichuan 610083, China.
Zhongyong JiangDepartment of Medical Laboratory, The General Hospital of Western Theater Command, Chengdu, Sichuan 610083, China.
Chengdu Military General Hospital · CNChengdu Medical College · CNSichuan Center for Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lupus nephritis (LN) has a high incidence in systemic lupus erythematosus (SLE) patients, but there is a lack of sensitive predictive markers. The purpose of the study was to investigate the association between the CD4

Indexed as

CD4+CD8+ double positive T cellslupus nephritissusceptibilitysystemic lupus erythematosus

Identifiers

PMID36625011
PMCPMC9898043
OpenAlexW4296281355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.